Monoclonal antibodies companies
Companies whose enriched business profile is tagged “Monoclonal antibodies”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.
- NOVARTIS AG (NVS) Health Care — Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases. ask →
- TG THERAPEUTICS INC (TGTX) Health Care — TG Therapeutics is a commercial-stage biotechnology company driving growth through its FDA-approved multiple sclerosis therapy, BRIUMVI, and an expanding pipeline of B-cell disease treatments. ask →
- ORUKA THERAPEUTICS INC (ORKA) Health Care — Oruka Therapeutics is a clinical-stage biotech developing engineered monoclonal antibodies to set a new standard of care in chronic skin diseases like psoriasis. ask →
- Hemab Therapeutics Holdings, Inc. (COAG) Health Care — Hemab Therapeutics is a clinical-stage biotechnology company developing innovative bispecific and monovalent antibody therapies for rare blood coagulation disorders. ask →
- ZENAS BIOPHARMA INC (ZBIO) Health Care — Clinical-stage immunology company developing obexelimab, a novel bifunctional monoclonal antibody targeting B cells for the treatment of autoimmune diseases. ask →
- CLIMB BIO INC (CLYM) Health Care — Clinical-stage biotech developing budoprutug, an anti-CD19 monoclonal antibody for B-cell depletion in autoimmune diseases including membranous nephropathy and lupus. ask →
- SHATTUCK LABS INC (STTK) Health Care — Shattuck Labs is a clinical-stage biotech developing novel protein therapeutics to treat inflammatory and immune-mediated diseases by targeting the DR3/TL1A pathway. ask →
- PROTHENA PLC (PRTA) Health Care — A clinical-stage biotech developing antibody therapies targeting misfolded proteins in Parkinson's disease, Alzheimer's disease, and rare amyloidosis through proprietary CYTOPE® intracellular delivery technology, in partnership with major pharma. ask →
Not quite it? Describe exactly what you want →
Frequently asked
What are the largest monoclonal antibodies companies?
By market capitalization, the largest monoclonal antibodies companies in the catalog include NOVARTIS AG (NVS), TG THERAPEUTICS INC (TGTX), ORUKA THERAPEUTICS INC (ORKA), Hemab Therapeutics Holdings, Inc. (COAG), ZENAS BIOPHARMA INC (ZBIO).
How many monoclonal antibodies companies does stocks-llm track?
stocks-llm currently lists 8 monoclonal antibodies companies (as of 2026-08-24), each with dated fundamentals from SEC EDGAR and market data. Informational only — not financial advice.
Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.